Physician profile
Peter J Johnson
NPI 1053517151
$1,326.08
in general payments reported to CMS, 2019-2025
15 companies · $21.14 in 2025
The $21.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2021: $19.77 · 2022: $915 · 2023: $56.12 · 2024: $14.93 · 2025: $21.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $879.79 | 2022 | |
| Abbvie INC. | $71.96 | 2019 | |
| Pfizer INC. | $53.65 | 2019-2024 | |
| Hologic Sales and Service, LLC | $49.69 | 2019-2023 | Acessa Provu System |
| Daiichi Sankyo INC. | $45.79 | 2021-2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $44.26 | 2019 | |
| Amag Pharmaceuticals, INC. | $39.30 | 2019 | |
| Merck Sharp & Dohme LLC | $24.80 | 2019 | |
| Astellas Pharma US INC | $21.14 | 2025 | Veozah |
| Mylan Pharmaceuticals INC. | $20.01 | 2019 | |
| Medtronic, INC. | $19.53 | 2022 | |
| Boston Scientific Corporation | $18.04 | 2019 | |
| Roche Diagnostics Corporation | $17.69 | 2019 | |
| Dysis Medical, INC. | $11.61 | 2019 | |
| Organon LLC | $8.82 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.